Hyloris appoints Patrick Jeanmart as Chief Financial Officer

Published On: 28 May 2020

Mr. Jeanmart has over 20 years of experience as a finance executive, including the last 15 years in the biotechnology and pharmaceutical industry and has significant experience in implementing financial and operational strategies. Mr. Jeanmart recently served as Global Head of Healthcare at Degroof Petercam Investment Bank. Between 2007 and 2018, he served as Chief Financial Officer of Celyad, where he participated successfully in its development, first as a private and then as a public company (Euronext Brussels, Paris and NASDAQ). Prior to joining Celyad, he served at IBA for six years, where he held a number of senior financial management positions.

Stijn Van Rompay, Chief Executive Officer and co-founder of Hyloris, commented: “As an accomplished CFO, we are delighted to welcome Patrick to Hyloris. He brings a wealth of experience that will be invaluable to Hyloris and the executive management as we ramp up activities to deliver pharmaceutical products with added value and develop our commercialisation strategy.”

Commenting on his appointment, Patrick Jeanmart added: “I am pleased to be joining the highly capable team of Hyloris at this exciting time for the business. With a differentiated approach in developing new formulations of existing drugs, Hyloris has great potential to deliver significant value to the healthcare system. I look forward to working with the team towards this mission and assist in bringing improved treatments to patients in underserved markets.”